Theravance Biopharma, Inc. (TBPH) insider have most recently took part in a trading activity. On Aug 21, 2017 Pasqualone Frank, SVP, Chief Comm Ops Officer bought 4,000 shares having total worth of $105,360 at the price of $26.34 per share, following the transaction a total of 213,180 shares owned by Pasqualone Frank.
The stock has experienced a total of 4 insider trades in the past three months. These trades include 4 buy trades. Furthermore, over the past 12 months , the stock was traded 8 times by insiders. In 4 of these trades, the insider was a seller while an employee of the company was the buyer in 4 instances.
|Time Frame||Number of Insider Buy||Number of Insider Sell||Stock Price Change(%)|
Shares of Theravance Biopharma, Inc. (TBPH) traded up 3.58% on Aug 22, 2017, hitting $27.45. 137,299 shares of the company’s stock traded hands. Theravance Biopharma, Inc. has a 52 week low of $16.96 and a 52 week high of $42.56. The company’s market cap is $1,770 million.
Theravance Biopharma, Inc. (TBPH) last announced its earnings results on Aug 8, 2017. The company reported -1.27 earnings per share (EPS) for the quarter, lower than the consensus estimate of -1.14 by $0.13. The company had revenue of $3 million for the quarter, compared to the consensus estimate of $5 million. During the same quarter in the previous year, the company posted -1.06 earnings per share. The company’s revenue for the quarter was down 44% on a year-over-year basis.
|earnings per share||-1.27||-1.27||-1.36||-0.73||-1.06||-1.10||-1.23||-1.40||-1.42||-1.72|
Latest posts by William White (see all)
- Insider Trading Review: FS Investment Corporation $FSIC - January 13, 2018
- Insider Trader Watch: ENERTOPIA CORP $ENRT - January 13, 2018
- Insider Trading in Focus: Swiss Helvetia Fund, Inc. (The) $SWZ - January 13, 2018